Delivery Order SPE2DR25D2014-SPE2DR26FA1A2
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Voriconazole 200 mg tablets in quantities of 30 units, with a ceiling value of $4,455.00. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract executed through open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Voriconazole 200 mg tablets (30-count) with a ceiling value of $14,633.76. This firm fixed-price, competitively awarded contract was finalized on July 28, 2025, with an ultimate completion date of July 29, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order does not include a set-aside designation and represents a tactical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,948.35 to AmerisourceBergen Drug Corp for the supply of Voriconazole 200 mg tablets in quantities of 30 units. This non-competitive, firm fixed-price delivery order was executed on July 23, 2025, with an ultimate completion date of July 24, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office. This award represents a child contract, indicating...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Voriconazole 200 mg tablets in unit dose packages of 30 units. This contract, valued at $4,341.78, represents a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 29, 2025. This...
- This is a federal contract award made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,771.88 firm fixed-price delivery order is for the supply of 4,567,157,701 units of Voriconazole 200 mg tablets. The contract has an ultimate completion date of February 5, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $3,683.31 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for 4,564,274,187 units of the pharmaceutical product VORICONAZOLE 200 MG TABLET 30S. This delivery order was issued against an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp to provide a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,247,511 units of the pharmaceutical product VORICONAZOLE 200 MG TABLET 30S. The contract has a ceiling value of $1,958.98 and a period of performance through April 12, 2024. Amerisourcebergen Drug Corp is the prime contractor for this award, which is not associated with any set-aside designations. This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,409.19 Delivery Order contract is for the supply of 4,566,120 units of 200mg Voriconazole tablets. The contract has a period of performance through October 17, 2024 and utilizes a Firm Fixed Price pricing structure. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VORICONAZOLE 200 MG TABLET 30S. The contract has a firm fixed price of $6,045.67 and a completion date of November 1, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which...
- The Defense Logistics Agency awarded a $46,000 delivery order to Amerisourcebergen Drug Corporation for 200 milligram vials of the antifungal medication voriconazole. The firm fixed price order is being fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania for delivery to an unknown customer of the Defense Logistics Agency. No additional details were provided regarding the context or purpose of this small, short-term order, which is being funded through the Defense...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FA1A2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,926.16 to AmerisourceBergen Drug Corp for the supply of Voriconazole 200 mg tablets in quantities of 30 units. This non-competitive, firm fixed-price delivery order was awarded on December 30, 2025, with an ultimate completion date of December 31, 2025. The pharmaceutical products will be delivered to the place of performance located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. Voriconazole is an antifungal medication commonly used in military and federal healthcare systems to treat serious fungal infections. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. As the prime contractor on this comprehensive pharmaceutical support vehicle, AmerisourceBergen Drug Corp supplies a broad range of medications and medical supplies to support military healthcare programs globally, including support for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's demonstrated capability in federal pharmaceutical procurement, coupled with its position as a major healthcare solutions provider, positions it as a critical vendor within the federal medical supply chain for military and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 12/29/25 |